Cantor Fitzgerald Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $5
Cantor Fitzgerald Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $5
坎托·菲茨杰拉德以增持评级启动对Connect Biopharma Hldgs的报道,宣布目标股价为5美元
Cantor Fitzgerald analyst Louise Chen initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight rating and announces Price Target of $5.
坎托·菲茨杰拉德分析师路易丝·陈以增持评级开始对Connect Biopharma Hldgs(纳斯达克股票代码:CNTB)进行报道,并宣布目标股价为5美元。